Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Non-Current Debt: 2024-2025

Historic Non-Current Debt for Editas Medicine (EDIT) over the last 1 years, with Sep 2025 value amounting to $54.1 million.

  • Editas Medicine's Non-Current Debt was N/A to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year change of. This contributed to the annual value of $52.4 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Editas Medicine's Non-Current Debt stood at $54.1 million, which was up 4.64% from $51.7 million recorded in Q2 2025.
  • Editas Medicine's 5-year Non-Current Debt high stood at $54.1 million for Q3 2025, and its period low was $49.6 million during Q1 2025.
  • Its 2-year average for Non-Current Debt is $51.9 million, with a median of $52.1 million in 2024.